Vimarsana
Biggest News Aggregation in the World

Charanjit Rihal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Charanjit Rihal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Charanjit Rihal Today - Breaking & Trending Today

TAVI Proficiency Doesn't Spell Success for M-TEER at Large US Sites - Vimarsana News

TAVI Proficiency Doesn't Spell Success for M-TEER at Large US Sites

Just one in nine US centers had similar short-term outcomes with TAVI and M-TEER, say researchers.

Source: tctmd.com
Reassuring Registry Data on Going Into TAVR Sans Symptoms - Vimarsana News

Reassuring Registry Data on Going Into TAVR Sans Symptoms

Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis?

Conversations in Cardiology: For Physicians, How Old Is Too Old? - Vimarsana News

Conversations in Cardiology: For Physicians, How Old Is Too Old?

Some hospitals are requiring tests to gauge competency—how best to balance wisdom with the inevitable declines of age.

Source: tctmd.com
Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis - Vimarsana News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Access to genetic tests is limited right now, but experts call for industry to develop new technologies that can be easily used.

Source: tctmd.com
'Smart' Approach Wins for Post-PCI Antiplatelet Prescribing - Vimarsana News

'Smart' Approach Wins for Post-PCI Antiplatelet Prescribing

April 19, 2021 Selecting a post-PCI antiplatelet regimen based on platelet function or genetic testing seems to improve both efficacy and safety, according to a new meta-analysis. Its authors say the results support the next frontier of personalized medicine despite the lack of randomized trial evidence. Prior studies, like last year’s TAILOR-PCI, have failed to establish the superiority of a guided antiplatelet strategy over standard therapy, but proponents say no trial so far has been accurately powered to do so. This 20,000-patient meta-analysis, which combined the TAILOR-PCI, POPular Ge...

Source: tctmd.com